Literature DB >> 448577

Rifampin for CSF shunt infections caused by coagulase-negative staphylococci.

J C Ring, K L Cates, K K Belani, T L Gaston, R J Sveum, S C Marker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 448577     DOI： 10.1016/s0022-3476(79)80682-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

1.  Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage.

Authors:  R Bayston; C A Hart; M Barnicoat
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

Review 2.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

3.  Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes.

Authors:  C U Tuazon; D Shamsuddin; H Miller
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

4.  Rifampin for therapy of experimental pneumococcal meningitis in rabbits.

Authors:  R Nau; K Kaye; M Sachdeva; E R Sande; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.